GNT Pharma Co., Ltd

In the past few months, South Korean bioventures, including ABL Bio , have clinched a series of large-scale global out-licensing deals, dominating the transactions in the country so far this year. So

The hopes of spring may be returning to the South Korean biotech industry after a series of encouraging developments in recent months has more than made up for some other disappointing news, with prog

A selection of key stories and an audio interview from the past few weeks from the Asia-based content team for Scrip and the Pink Sheet , reflecting the diversity and depth of issues facing the bio

Bioventure GNT Pharma Co., Ltd has received approval from South Korea's Ministry of Food and Drug Safety to begin a Phase III study with its first-in-class, multi-targeted stroke therapy nelonemdaz,